Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tirzepatide's dual action produces up to 22% weight losssignificantly more effective at eliminating visceral fat than single-target medications
Zhao et al., 2008
For the most recent prescribing information, please visit www.pfizer.com
Food and Drug Administration Wegovy (semaglutide) prescribing information Official dosing, administration, and safety labeling Medication Manufacturer Instructions Novo Nordisk Wegovy Injection Instructions Official injection technique and pen usage Eli Lilly and Company Mounjaro (tirzepatide) Instructions for Use Proper administration and dosing schedule Evidence-Based Research New England Journal of Medicine Once-Weekly Semaglutide in Adults with Overweight or Obesity Landmark clinical trial demonstrating weight loss outcomes National Institutes of Health GLP-1 receptor agonists for obesity treatment Mechanism and long-term effectiveness
US$ 29.79
US$ 20.55
US$ 27.42
US$ 22.07
US$ 27.16
